Control4 (CTRL)’s SVP of Sales Bryce Judd Sold 1042 shares of the Company; Celsion (CLSN) Sellers Decreased By 16.67% Their Shorts

April 4, 2018 - By Jerrie Dane

Celsion Corporation (NASDAQ:CLSN) Logo

Celsion Corporation (NASDAQ:CLSN) had a decrease of 16.67% in short interest. CLSN’s SI was 1.11 million shares in April as released by FINRA. Its down 16.67% from 1.33M shares previously. With 313,600 avg volume, 4 days are for Celsion Corporation (NASDAQ:CLSN)’s short sellers to cover CLSN’s short positions. The stock increased 2.01% or $0.04 during the last trading session, reaching $2.03. About 70,465 shares traded. Celsion Corporation (NASDAQ:CLSN) has declined 35.14% since April 4, 2017 and is downtrending. It has underperformed by 46.69% the S&P500.

Celsion Corporation, an oncology drug company, focuses on the development and commercialization of directed chemotherapy, DNA-mediated immunotherapy, and RNA based therapy products for the treatment of cancer. The company has market cap of $36.01 million. The companyÂ’s lead product includes ThermoDox, a liposomal encapsulation of doxorubicin that is in Phase III clinical trials for primary liver cancer; and under Phase II clinical trials for recurrent chest wall breast cancer. It currently has negative earnings. It is also developing GEN-1, a DNA immunotherapeutic product for the localized treatment of ovarian and brain cancers.

Among 2 analysts covering Celsion (NASDAQ:CLSN), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Celsion had 9 analyst reports since August 7, 2015 according to SRatingsIntel. The firm has “Buy” rating by Maxim Group given on Tuesday, January 19. Maxim Group maintained the stock with “Hold” rating in Thursday, June 1 report. Cantor Fitzgerald maintained it with “Buy” rating and $7 target in Friday, August 7 report. The company was downgraded on Thursday, November 10 by Maxim Group. Zacks upgraded it to “Hold” rating and $2.50 target in Wednesday, August 12 report. Maxim Group maintained the shares of CLSN in report on Tuesday, August 15 with “Hold” rating. The stock has “Buy” rating by Maxim Group on Thursday, October 5. The firm earned “Hold” rating on Monday, August 7 by Maxim Group. Oppenheimer initiated it with “Buy” rating and $9.0 target in Monday, November 20 report.

Company insider, Bryce Judd, SVP of Sales of Control4 Corp unloaded a total of 1,042 shares of the firm, based on an average price of $21.4 for share. Bryce Judd now possess 461 shares or 0.00% of Control4 Corp’s market cap.

Analysts await Control4 Corporation (NASDAQ:CTRL) to report earnings on May, 3. They expect $0.03 earnings per share, up 400.00% or $0.04 from last year’s $-0.01 per share. CTRL’s profit will be $780,626 for 175.21 P/E if the $0.03 EPS becomes a reality. After $0.30 actual earnings per share reported by Control4 Corporation for the previous quarter, Wall Street now forecasts -90.00% negative EPS growth.

The stock decreased 0.69% or $0.145 during the last trading session, reaching $21.025. About 80,091 shares traded. Control4 Corporation (NASDAQ:CTRL) has risen 46.17% since April 4, 2017 and is uptrending. It has outperformed by 34.62% the S&P500.

Control4 Corporation provides smart home and business solutions for the connected home or business in the United States, Canada, and internationally. The company has market cap of $547.09 million. It offers Control4 solution that functions as the operating system of the home, integrating audio, video, lighting, temperature, security, communications, and other devices in the home automation market. It has a 35.04 P/E ratio. The company??s Control4 product line comprises the Control4 home operating system and the associated application software, and software development kits .

Since February 13, 2018, it had 0 insider purchases, and 13 selling transactions for $6.03 million activity. The insider Bishop Greg sold $153,123. Judd Bryce had sold 19,073 shares worth $476,253 on Tuesday, February 20. 15,582 shares were sold by Cashen Susan, worth $389,238 on Tuesday, February 20. $706,831 worth of Control4 Corporation (NASDAQ:CTRL) was sold by Novakovich Mark on Tuesday, February 20. $1.02 million worth of Control4 Corporation (NASDAQ:CTRL) shares were sold by PLAEHN MARTIN.

Control4 Corporation (NASDAQ:CTRL) Institutional Positions Chart